title: [Significens of blood platelet CD62p in treating sudden deafness].
abstract: OBJECTIVE
  To compare different treatment methods for sudden deafness of different blood platelet CD62p levels.
  
  
  METHODS
  Blood platelet was measured with flow cytometer. Patients with platelet CD62p over or less than 2% were treated with routine treatment (low molecular weight dextran, ATP, CoA and dexamethasone) or routine treatment plus batroxobin (thrombolysis) separately.
  
  
  RESULTS
  In the group with platelet CD62p > or = 2%, the effective rates of routine treatment was 60.5%, and that of routine treatment plus thrombolysis was 84.6%. There was significant difference between them. In the group with platelet CD62p < 2%, the effective rates of two methods were 65.0% and 71.8% respectively(no significant difference between them).
  
  
  CONCLUSIONS
  Detecting CD62p in sudden deafness patients makes sense for deciding treatment project.
authors.affiliation: Department of Otorhinolaryngology, First Hospital of Shanxi Medical University, Taiyuan 030001, China. cxbxx@public.ty.sx.cn
authors.forename: Qinna
authors.initials: Q
authors.lastname: Zhang
authors.forename: Liping
authors.initials: L
authors.lastname: Zhang
authors.forename: Lijun
authors.initials: L
authors.lastname: Xia
authors.forename: Yanqiu
authors.initials: Y
authors.lastname: Chen
authors.forename: Jianming
authors.initials: J
authors.lastname: Wang
authors.forename: Binquan
authors.initials: B
authors.lastname: Wang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D003639:Hearing Loss, Sudden / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019007:P-Selectin / Q000097:blood*; D015539:Platelet Activation; D015912:Thrombolytic Therapy
chemical_list: D019007:P-Selectin